Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

R&D Consortium to Develop Optical Sorting of Stem Cells

Published: Tuesday, December 17, 2013
Last Updated: Tuesday, December 17, 2013
Bookmark and Share
Dolomite is collaborating with European technology leaders over a two year publicly funded consortium.

Danish project partners OptoRobotix (R&D performing SME) and Bioneer (technological service partner) and Dolomite will jointly develop a cutting edge stem cell handling technology. As the market leader in microfluidic design, Dolomite will exploit its latest offerings to transform from concept to biotech device. The collaboration recognizes Dolomite’s proven track of Productizing Science®, its unique business philosophy. 

Named OPTISORT (E! 7790 OPTISORT), the platform is expected to provide ‘Sorting and analysis platform for fragile mammalian cells using novel combination of optical and droplet technology’. The areas of stem cell biology and mammalian cell based protein manufacturing are developing fast. The ability for gentle cell sorting technologies and methods is expected to enable customers exploit unprecedented applications of cell biology in technology. The Consortium combines novel optical and droplet technology to create a commercial attractive platform. The collaboration has awarded close to 1 million Euros with a view to benefit the biotechnology, pharmaceutical and molecular biology industry. 

The collaboration is made possible by the Eurostars Programme – a European Joint Programme dedicated to the R&D performing SMEs, co-funded by the European Communities and 33 EUREKA member countries. Eurostars aims to stimulate SMEs with a promising potential for international collaborative research and innovation, enabling the route to international markets. Eurostars, the first European funding programme dedicated to innovation driven SMEs highlights their importance as essential sources of growth, employment, entrepreneurial skills, innovation and economic and social cohesion. On average, a Eurostars project has 3 to 4 Participants, 2-3 Countries, 29 Months duration, and €1.4M R&D budget. Of a total of 9807 applicants, 613 Projects were successfully funded with a total budget of €878M (€390M Estimated Public Funding).


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Stem Cells Rescue Patients from Mitochondrial Disease
A study led by OHSU researchers has revealed a critical first step in developing a new gene and stem cell regenerative technique for treating patients with mitochondrial disease.
Eco-Friendly Nanobullet to Battle Bacteria
Researchers have developed a method to combat bacteria by engineering nanoscale particles that add the antimicrobial potency of silver to a core of lignin, a ubiquitous substance found in all plant cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!